Procurement Report: Simvastatin (API & Reference Standards)

Product Category: Pharmaceutical Active Pharmaceutical Ingredient (API) & Certified Reference Material (CRM) Chemical Name: Simvastatin CAS Number: 79902-63-9 Primary Function: HMG-CoA Reductase Inhibitor (Hypolipidemic Agent)

---

1. Technical Specifications and Performance Metrics

When sourcing Simvastatin for pharmaceutical manufacturing or quality control laboratories, precise technical parameters are critical to ensure batch consistency and regulatory compliance. The product exists primarily in two forms: bulk API for formulation and Certified Reference Materials (CRMs) for analytical validation.

• Assay/Purity: For pharmaceutical-grade API and reagent use, the assay typically ranges from 97.0% to 99.5%. Bulk API intended for direct tablet manufacturing often targets the 98.0%–99.0% range to account for excipient interactions.
• Impurity Limits: Procurement specifications must strictly define limits for related substances (e.g., Simvastatin acid, diastereomers). Typical B2B limits for individual unspecified impurities are ≤ 0.10%, with total impurities generally capped at ≤ 1.0%.
• Crystal Form: Simvastatin exhibits polymorphism. The stable crystalline form is the preferred specification for manufacturing to ensure dissolution consistency. Buyers should request X-ray Powder Diffraction (XRD) data to confirm the specific crystal lattice.
• Moisture Content: To prevent hydrolysis of the lactone ring, moisture content should be maintained at ≤ 0.5% (Karl Fischer titration).
• Particle Size: For API, a D90 particle size of < 50 µm is typical for direct compression, while CRMs often require micronized grades for homogeneity in analytical balances.
• Lead Time & MOQ: Typical B2B lead times for bulk API are 4–8 weeks post-order confirmation. Minimum Order Quantities (MOQ) usually start at 1 kg for API and 100 mg for CRMs.

Actionable Recommendation: Prioritize suppliers who provide a Certificate of Analysis (COA) with lot-specific data for assay, moisture, and specific impurity profiles (e.g., HMGCR-related impurities) rather than generic specifications. Always verify the crystal form in the technical data sheet before finalizing the purchase order.

2. Industry Compliance and Quality Assurance

Simvastatin is a regulated substance with specific safety and quality requirements. Compliance is non-negotiable for both API manufacturers and reference material suppliers.

• Regulatory Traceability: High-grade Simvastatin must be traceable to major pharmacopeial standards, specifically USP (United States Pharmacopeia) and Ph. Eur. (European Pharmacopoeia). Look for traceability codes such as USP 1612700 or Ph. Eur. S0650000 in the documentation.
• GHS Classification & Safety: The substance is classified under GHS08 (Health Hazard) with the signal word Warning.
  • Hazard Codes: H361d (Suspected of damaging fertility or the unborn child).
  • Precautionary Statements: P201, P202, P280, P308+P313, P405, P501.
  • Storage Class: Classified as Class 11 (Combustible Solids) in certain jurisdictions, though flash point is generally not applicable.
• Quality Systems: Suppliers should operate under cGMP (Current Good Manufacturing Practices). For CRMs, the material should be certified as a "Pharmaceutical Secondary Standard," ensuring it serves as a cost-effective alternative to in-house working standards while maintaining traceability.
• Documentation: A valid COA is mandatory. Example verification codes (e.g., LRAB3719) are often used to access specific lot certificates online.

Actionable Recommendation: Require a full COA with every shipment. Verify that the supplier explicitly states traceability to USP or Ph. Eur. standards. Ensure your internal safety protocols align with the GHS08 classification, specifically regarding reproductive toxicity (H361d) and the requirement for PPE (P280).

3. Cost Efficiency and Integration Capabilities

Procuring Simvastatin involves balancing the cost of high-purity API against the need for rigorous quality control, particularly when dealing with secondary standards.

• Cost Drivers: The cost per kilogram for API varies based on purity (97% vs. 99.5%) and the scale of purchase. CRMs are priced significantly higher per gram due to the certification process and traceability requirements.
• Integration: Simvastatin integrates seamlessly into existing HPLC (High-Performance Liquid Chromatography) and UPLC workflows used for potency testing and impurity profiling.
• Secondary Standards: Utilizing Certified Pharmaceutical Secondary Standards can reduce long-term costs by eliminating the need for in-house synthesis of working standards, which requires validation and stability testing.
• MOQ Flexibility: Suppliers offering tiered pricing for bulk (1kg+) versus analytical (100mg) quantities allow for better cash flow management for R&D vs. production teams.

Actionable Recommendation: For routine QC testing, procure Certified Secondary Standards rather than raw API to reduce validation overhead. For production, negotiate volume discounts on API with a 12-month supply contract to mitigate price volatility. Ensure the supplier's logistics capabilities align with your storage requirements (combustible solids classification).

4. Typical Use Cases

Simvastatin is a cornerstone drug in lipid management, driving demand across several specific sectors.

• Hypercholesterolemia Treatment: The primary application is the formulation of oral tablets and capsules to lower plasma cholesterol by inhibiting HMG-CoA reductase.
• Quality Control (QC) Laboratories: Used as a reference standard to calibrate analytical instruments and validate the purity of finished drug products.
• Stability Studies: Employed in forced degradation studies to assess the stability of the lactone ring under various pH, temperature, and light conditions.
• Method Development: Used by analytical chemists to develop and validate new HPLC methods for detecting Simvastatin and its degradation products in complex matrices.
• Research & Development: Utilized in academic and industrial research to study the mechanism of action regarding HMGCR inhibition and lipid metabolism.

Actionable Recommendation: Match the product grade to the use case. Use Pharmaceutical Secondary Standards for routine QC calibration and High-Purity API (99%+) for method development and formulation. Do not use raw API for instrument calibration unless it has been certified as a reference material.

5. Long-Term Planning Considerations

Strategic procurement of Simvastatin requires anticipating market shifts and regulatory changes.

• Market Demand Signals: As global cardiovascular disease rates rise, demand for generic statins remains stable. However, the market is increasingly shifting toward combination therapies (e.g., Simvastatin + Ezetimibe), which may alter the volume requirements for pure Simvastatin API.
• Regulatory Evolution: Stricter impurity limits (e.g., N-nitrosamine concerns in the broader API sector) may necessitate more frequent supplier audits.
• Supply Chain Resilience: Given the "Combustible Solids" classification and specific storage needs, reliance on a single supplier poses a risk. Diversifying suppliers across different geographic regions is advisable.
• Sustainability: Future procurement should prioritize suppliers with documented environmental, social, and governance (ESG) practices, particularly regarding solvent recovery in synthesis.

Actionable Recommendation: Develop a dual-sourcing strategy for critical API needs. Monitor regulatory updates from the FDA and EMA regarding statin impurities. Plan for a 2-year inventory buffer of CRMs to ensure continuity in QC operations during supply disruptions.

6. Special Product Recommendations

The following table compares the primary product types available for Simvastatin to assist in selecting the right material for your specific operational needs.

| Product Type | Best-Fit Buyer | Key Specs | Risk Check | Procurement Advice | | :--- | :--- | :--- | :--- :--- | | Certified Reference Material (CRM) | QC Labs / R&D | Assay: 99.5%+; Traceable to USP/Ph. Eur.; Lot-specific COA | High (Single source dependency) | Use for instrument calibration and method validation. Verify traceability code (e.g., USP 1612700). | | Pharmaceutical Secondary Standard | Manufacturing QC | Assay: 97–99.5%; Cost-effective alternative to primary standards | Medium (Stability over time) | Ideal for routine daily testing. Check expiration dates and storage stability data. | | Bulk API (97–99%) | Formulation Plants | Assay: 97–99%; Impurity <1%; Moisture <0.5% | High (Batch variability) | Require full batch release testing. Confirm crystal form stability. | | Reagent Grade | Academic Research | High purity; Lower regulatory documentation | Low (Not for human use) | Suitable only for non-clinical research. Do not use for GMP manufacturing. |

Actionable Recommendation: For any product intended for human use or regulatory submission, strictly avoid "Reagent Grade" and insist on "Pharmaceutical Grade" or "CRM" status. Always request the specific lot number to cross-reference with the online COA database.

7. Frequently Asked Questions (FAQ)

Q1: What is the typical purity range for Simvastatin API intended for tablet manufacturing? A: The typical assay range is 97.0% to 99.5%. Most manufacturers target 98.0%–99.0% to ensure consistent dosing after accounting for excipients.

Q2: How do I verify the authenticity of a Simvastatin Certificate of Analysis (COA)? A: Many suppliers provide a unique verification code (e.g., LRAB3719) on the COA. Enter this code into the supplier's portal to view the specific lot data, ensuring it matches the physical shipment.

Q3: What are the specific storage requirements for Simvastatin? A: Simvastatin is classified as a Combustible Solid (Class 11). It must be stored in a cool, dry place away from ignition sources. Due to the H361d hazard, it requires strict containment to prevent exposure to personnel.

Q4: Is Simvastatin available as a Certified Reference Material traceable to USP? A: Yes. Certified Secondary Standards are available that are traceable to USP 1612700 and Ph. Eur. S0650000, making them suitable for quality control in regulated environments.

Q5: What is the typical lead time for ordering bulk Simvastatin API? A: Typical B2B lead times range from 4 to 8 weeks after order confirmation, depending on the supplier's current production schedule and raw material availability.

Q6: Are there specific impurity limits I should enforce in my purchase order? A: Yes. Standard industry limits usually require individual unspecified impurities to be ≤ 0.10% and total impurities ≤ 1.0%. Specific degradation products should be defined in your technical agreement.

Q7: Can Simvastatin be used for non-pharmaceutical research? A: While "Reagent Grade" Simvastatin exists for academic research, it is not suitable for human use or GMP manufacturing. Ensure the grade matches your intended application to avoid regulatory violations.

Q8: What GHS hazard symbols apply to Simvastatin? A: Simvastatin carries the GHS08 (Health Hazard) pictogram. The signal word is Warning, and it includes the hazard statement H361d (Suspected of damaging fertility or the unborn child).